tiprankstipranks
Trending News
More News >
Clearside Biomedical (CLSDQ)
OTHER OTC:CLSDQ
US Market

Clearside Biomedical (CLSDQ) Financial Statements

Compare
1,068 Followers

Clearside Biomedical Financial Overview

Clearside Biomedical's market cap is currently $2.20M. The company's EPS TTM is $; its P/E ratio is -0.87; Clearside Biomedical is scheduled to report earnings on March 5, 2026, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 1.66M$ 8.23M$ 1.33M$ 29.57M$ 7.89M
Gross Profit$ 1.51M$ 7.87M$ 1.12M$ 29.57M$ 7.89M
Operating Income$ -28.88M$ -24.84M$ -30.28M$ -627.00K$ -17.93M
EBITDA$ -24.35M$ -23.06M$ -29.46M$ 554.00K$ -17.70M
Net Income$ -34.35M$ -32.48M$ -32.95M$ 376.00K$ -18.21M
Balance Sheet
Cash & Short-Term Investments$ 20.02M$ 28.92M$ 48.42M$ 30.44M$ 17.29M
Total Assets$ 25.13M$ 34.02M$ 51.30M$ 42.90M$ 19.32M
Total Debt$ 52.47M$ 43.00M$ 35.26M$ 675.00K$ 1.98M
Net Debt$ 32.45M$ 14.08M$ -13.16M$ -29.76M$ -15.31M
Total Liabilities$ 63.98M$ 49.93M$ 40.70M$ 4.93M$ 10.56M
Stockholders' Equity$ -38.85M$ -15.91M$ 10.61M$ 37.98M$ 8.76M
Cash Flow
Free Cash Flow$ -25.68M$ -19.91M$ -13.61M$ -10.73M$ -13.18M
Operating Cash Flow$ -24.70M$ -18.14M$ -13.37M$ -10.73M$ -13.12M
Investing Cash Flow$ -638.00K$ -1.78M$ -246.00K$ 0.00$ -55.00K
Financing Cash Flow$ 16.44M$ 414.00K$ 31.33M$ 23.78M$ 7.87M
Currency in USD

Clearside Biomedical Earnings and Revenue History

Clearside Biomedical Debt to Assets

Clearside Biomedical Cash Flow

Clearside Biomedical Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.